Disc Medicine

Company snapshot

Disc Medicine maintains 308 tracked programs across Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falciparum malaria, Glioblastoma, Breast cancer, Primary aldosteronism, Locally advanced rectal cancer, HIV-1, Chronic Kidney Disease, PASC: post-acute sequelae of SARS-CoV-2 infection, EGFR mutated locally advanced or metastatic non-small cell lung cancer. Momentum score: 20/100 (3

• 2 approved product(s) across US/EU regulatory metadata.
• 308 active pipeline program(s) linked via ClinicalTrials.gov.
• 706 US patent(s) indexed to this assignee profile.

Public regulatory, clinical, patent, and corporate records for Disc Medicine. Not investment advice.

• Peer + 0 momentum

  Anaxis Pharma

  TA overlap score 50

• Peer + 0 momentum

  Alaunos Therapeutics

  TA overlap score 26.8

Recent activity

Latest pipeline, patent, and corporate events for Disc Medicine.

1. Jun 14, 2026 Clinical update

   PaNaMa ID: 116348 — Approved

2. Jun 14, 2026 Clinical update

   PaNaMa code: 113071 — Approved

3. Jun 8, 2026 Clinical update

   NL77785.078.21 — Approved

4. Jun 8, 2026 Clinical update

   Sodium Chloride Fresenius Kabi Italia 0.9 % S... — Approved

5. Jun 8, 2026 Clinical update

   Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr… — Approved

View all clinical trial activity →

• What is Disc Medicine?

  Disc Medicine is a pharma organization headquartered in Watertown, USA. It trades on NYSE under ticker IRON. Primary therapeutic focus areas include Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease, Falciparum malaria, Glioblastoma. NovaPharmaNews links 308 clinica

• Is Disc Medicine publicly traded?

  Yes. Disc Medicine is listed with ticker IRON on NYSE per SEC EDGAR records linked on this profile.

• What drugs does Disc Medicine develop or market?

  We link 443 drug profile(s) where Disc Medicine is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/disc-medicine#company-drugs.

• What are the latest developments for Disc Medicine?

  In the last 12 months our linked public records show 308 trial program update(s) and 19 US patent grant(s) tied to this profile.

• What therapeutic areas does Disc Medicine focus on?

  Disc Medicine focuses on Inflammatory Bowel Disease (IBD), Melanoma, Parkinson's disease based on our analysis of their pipeline programs and drug development activities.